skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Is now a good time to buy Facebook? Is there much room for more growth with this stock? What is the long term outlook?
Read Answer Asked by Grant on August 04, 2015
Q: Peter -any current thoughts on AIG AT THESE LEVELS??KIM
Read Answer Asked by Kim on August 03, 2015
Q: Hello

What are you thoughts on this stock? Would you consider this a good growth stock still?

Thanks
Dolores
Read Answer Asked on July 31, 2015
Q: Would you recommend I sell Delta Airlines and buy something like Allegiant Travel instead? Or another recommendation you have in the space.
Read Answer Asked by Andrew on July 31, 2015
Q: Could you give me your thoughts about PayPal (how expensive is the stock compared to it's peers? expected growth? balance sheet? and management?). I thought that I heard it was valued similar to VISA?

Thank you very much. Scott
Read Answer Asked by Scott on July 30, 2015
Q: Hello 5i Team,

The only US company I currently own is Boeing, and I would like to diversify with 1-2 more names. I know you don't formally cover US stocks, but I've been looking at Time Warner, Priceline, and Toll Brothers. Which would you recommend? Are there any others you would pick over those for a combination of growth and stability. I'd like to stay away from volatile small caps.

Thanks,

Jordan
Read Answer Asked by Jordan on July 30, 2015
Q: Hi Peter and Team,

Would you please comment on UTX's pull back of 20% over the last quarter.

Regards,

H.S.
Read Answer Asked by Harry on July 30, 2015
Q: Have a 4% position in Allergan (formerly Actavis). Would you recommend selling all or a portion given the Teva takeover of the generic drug division, or continuing to hold.
Read Answer Asked by Barbara on July 28, 2015
Q: I own Cigna. Would you wait for the deal to be approved by regulators or sell now?

THX
Read Answer Asked by Greg on July 27, 2015
Q: As the Cdn $ gets clobbered, can you recommend a few Canadian companies and/or sectors that would benefit from the weak loonie. Thanks M
Read Answer Asked by michael on July 27, 2015
Q: Can you give me your thoughts on the outlook for this company going forward?

Thank you
Read Answer Asked by Theresa on July 27, 2015
Q: Good morning,

Knowing you do not cover US stocks, what are your thoughts on the company slashing their forward profit and revenue forecast and its sales miss (3rd quarter in a row).
Would this be a good entry point or is it a catching a falling knife. Realizing the biotech sector is a risky one, but Biogen seems to have little debt and it is well diversified.
Thank you.
Elaine
Read Answer Asked by Elaine on July 27, 2015
Q: Hi Peter and Team!!! It gearing up for a great weekend weather wise, Yay! I have 16,000 to deploy in my RRSP. I would like to buy one or two ETFs that cover the US market, broadly and perhaps dividend aristocrats. VUN and VGG...are in Canadian funds. I would like the equivalent listed in US dollars, paying out in US dollars as well. I asked my investment advisor, and she could not give me any alternatives except for the SPY. Could you suggest some ? And on that topic, is it a good idea to hold another currency (in this case US dollars) in the RRSP, or just have an ETF representing the US market in Canadian funds? Thank you, and have a great weekend!! Cheers, Tamara
Read Answer Asked by Tamara on July 27, 2015
Q: I appreciate that this is a US holding and brand new, but just wanted to get your thoughts on its potential. Cyber security is getting a lot of press these days and I do not see this changing anytime soon. Is there any other ETF out there that does the same thing but with a lower MER?

Great job 5I Team and thanks.
Read Answer Asked by MARK on July 27, 2015
Q: Can you please take a look at this company. Could you tell me what your views are based on the most recent contracts awarded and the backlog. Looking at the charts and financials this company looks less expensive than many other in the sector. If the current price looks expensive to you, could you share what metrics you would look at for selecting a purchase price. Thank you Jason N.
Read Answer Asked by JASON on July 24, 2015
Q: UA recently posted earnings of $0.12 per share (down 14%)and revenues that were up 27% both on a 6 month basis. Guidance is that revenues for this year (2015) should grow 25% and operating income 14-15%. Last year earnings for the year were 0.95 so making a big assumption that EPS will grow also at 14% puts their P/E ratio at about $95/(0.95 x 1.14) ~ 88 !! Seems crazy high to me considering the stock is up over 7% today on the news. Am I looking at this right or is there some hidden value I'm not seeing? Thanks for your help as always.
Read Answer Asked by John on July 24, 2015
Q: Can I have your opinion on this fund which focuses on increasing dividends of companies with solid balance sheets. Would this be appropriate for a registered account which I shall not need to touch for about 5 years?

Thanks
Read Answer Asked by Ronald on July 24, 2015
Q: What do you think about Cinemark?

Compared to CGX trading at 35X trailing earnings CNK (23X)is a lot cheaper and should be able to grow faster in its markets and do more acquisitions.

I'm thinking about adding some on this pull back and before Q2 earnings are released which should be a record (Furious 7 and Jurassic World)
Read Answer Asked by Scott on July 24, 2015
Q: Hi 5i: Many thanks for the opinion on PANW and for the suggestion re FEYE. One problem I have with many high flying new companies is that most of the usual fundamental ratios are either negative or do not exist. What measures and/or ratios do you look at to assess the prospects of such companies? Thanks again.
Read Answer Asked by Roland on July 24, 2015
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!